Vogenx, Inc. (VOGX)
18.65
+0.42
(+2.30%)
USD |
NASDAQ |
Nov 06, 10:13
Vogenx Shareholders Equity (Quarterly) : -1.779M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.779M |
| Date | Value |
|---|---|
| March 31, 2026 | -1.400M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IGC Pharma, Inc. | 6.132M |
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| Arvinas, Inc. | 513.80M |
| Fulcrum Therapeutics, Inc. | 310.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.409M |
| Total Liabilities (Quarterly) | 3.188M |
| Debt to Equity Ratio | -0.4877 |
| Current Ratio | 0.0641 |